HOME › DRUGS › BELATACEPT
ACTIVE SUBSTANCE / INN

BELATACEPT

Brand name(s): Nulojix, NULOJIX
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA125288
Graft Rejection;Kidney Transplantation
ACTIVE SUBSTANCE
Belatacept
REGULATORS
FDA · EMA
SPONSORS / MAH
Bristol-Myers Squibb Pharma EEIG, BRISTOL MYERS SQUIBB
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NULOJIXBLA125288BRISTOL MYERS SQUIBBPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
NulojixBristol-Myers Squibb Pharma EEIGAuthorised17/06/2011Graft Rejection;Kidney Transplantation

FULL INTELLIGENCE ON BELATACEPT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →